Aligos Therapeutics (ALGS) Enterprise Value (QoQ) (2019 - 2026)
Aligos Therapeutics (ALGS) Enterprise Value (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.71 Bn | 130.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.60 Bn | 77.60 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.82 Bn | 59.63 Bn | 1.37 Bn |
| 4 | Moderna | 57.92 Bn | 52.79 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.88 Bn | 36.78 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.46 Bn | 28.15 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.96 Bn | 9.57 Bn | 668.28 Mn |
| 8 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Aligos Therapeutics | 68.32 Mn | 37.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 61.87% |
| Mar 31, 2026 | -333.55% |
| Dec 31, 2025 | 81.44% |
| Sep 30, 2025 | 56.33% |
| Jun 30, 2025 | -64.61% |
| Mar 31, 2025 | -142.38% |
| Dec 31, 2024 | 50.27% |
| Sep 30, 2024 | -21.06% |
| Jun 30, 2024 | 16.25% |
| Mar 31, 2024 | 16.85% |
| Dec 31, 2023 | -92.62% |
| Sep 30, 2023 | 22.41% |
| Jun 30, 2023 | -14.93% |
| Mar 31, 2023 | 37.16% |
| Dec 31, 2022 | -45.43% |
| Sep 30, 2022 | -21.53% |
| Jun 30, 2022 | 61.14% |
| Mar 31, 2022 | 2.03% |
| Dec 31, 2021 | 22.20% |
| Sep 30, 2021 | -26.09% |